Radiation oncologists at the Royal Adelaide Hospital (RAH) are leading the way with advanced radiotherapy treatments for pancreatic cancer. The AGITG MASTERPLAN study, coordinated by the NHMRC clinical trials centre at the University of Sydney, is testing the addition...
Speaking to Central Adelaide clinicians at a recent forum, Professor John Spertus outlined some of the evidence supporting the benefits of using capturing patient reported outcomes which can help clinicians in many ways. Focussing on what matters most to patients ...
Researchers at the Royal Adelaide Hospital (RAH) have tested a method of control of Parkinson’s disease symptoms that is safe and, for selected patients, provides more effective and consistent symptom control than oral medication. The new skin infusion method provides...
Survivors of critical illness face the risk of developing the ‘silent killer’ of type 2 diabetes, but it’s hoped new research will help detect at-risk patients early and prevent it. Associate Professor Mark Plummer, Head of Research and Innovation in the Intensive...
Vascular researchers have successfully used a revolutionary artificial skin-like template to treat complicated diabetic foot wounds, a development which could save hundreds of patients a year from foot amputations. A novel solution Reduced sensation in the feet,...
A nurse-led remote surveillance programme for vascular patients, has boosted patient participation to 100 per cent, saved hundreds of hours of clinician and patient time, and over $1.5 million of healthcare costs. The program is the first of its kind in Australia and...
